{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:34:47Z","timestamp":1791689687039,"version":"4.3.4"},"reference-count":33,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,7]]},"DOI":"10.14745\/ccdr.v42i01a03","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T16:05:22Z","timestamp":1519315522000},"page":"12-19","source":"Crossref","is-referenced-by-count":69,"title":["CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines"],"prefix":"10.14745","volume":"42","author":[{"given":"AK","family":"Boggild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Libman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Greenaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AE","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5795","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"key20180222110443_r1","unstructured":"World Health Organization. Intestinal Worms: Strongyloidiasis. Geneva: WHO; 2015. http:\/\/www.who.int\/intestinal_worms\/epidemiology\/strongyloidiasis\/en"},{"key":"key20180222110443_r2","unstructured":"Centers for Disease Control and Prevention. Parasites \u2013 Strongyloides. Epidemiology and risk factors. Atlanta GA: CDC; 2015. http:\/\/www.cdc.gov\/parasites\/strongyloides\/epi.html"},{"issue":"7","key":"key20180222110443_r3","doi-asserted-by":"crossref","first-page":"e2288","DOI":"10.1371\/journal.pntd.0002288","article-title":"Strongyloides stercoralis: global distribution and risk factors","volume":"7","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"key20180222110443_r4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.aje.a115655","article-title":"Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada","volume":"132","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"16","key":"key20180222110443_r5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14745\/ccdr.v40i16a01","article-title":"Travel-acquired infections in Canada: CanTravNet 2011 - 2012","volume":"40","year":"2014","journal-title":"Can Commun Dis Rep"},{"issue":"1","key":"key20180222110443_r6","first-page":"e20","article-title":"Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011","volume":"8","year":"2014","journal-title":"Open Med"},{"key":"key20180222110443_r7","unstructured":"Statistics Canada. Immigration and ethnocultural diversity in Canada. National Household Survey, 2011. Ottawa ON: Minister of Industry; 2015. http:\/\/www12.statcan.gc.ca\/nhs-enm\/2011\/as-sa\/99-010-x\/99-010-x2011001-eng.pdf"},{"key":"key20180222110443_r8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2334-11-84","article-title":"Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: the risk of infection and the diagnostic relevance of blood eosinophilia","volume":"11","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"2","key":"key20180222110443_r9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1708-8305.2010.00496.x","article-title":"Acute strongyloidiasis in Italian tourists returning from Southeast Asia","volume":"18","year":"2011","journal-title":"J Travel Med"},{"issue":"4","key":"key20180222110443_r10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1203475415575247","article-title":"Chronic larva currens following tourist travel to the Gambia and Southeast Asia over 20 years ago","volume":"19","year":"2015","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"key20180222110443_r11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1503\/cmaj.1031698","article-title":"Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management","volume":"171","year":"2004","journal-title":"CMAJ"},{"issue":"8","key":"key20180222110443_r12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jama.1966.03100080125044","article-title":"Strongyloidiasis and malignant lymphoma. \u201cOpportunistic infection\u201d by a nematode","volume":"195","year":"1966","journal-title":"JAMA"},{"issue":"7452","key":"key20180222110443_r13","first-page":"1396","article-title":"Steroid therapy and strongyloidiasis","volume":"1","year":"1966","journal-title":"Lancet"},{"issue":"20","key":"key20180222110443_r14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM196611172752003","article-title":"Fatal strongyloidiasis in patients receiving corticosteroids","volume":"275","year":"1966","journal-title":"N Engl J Med"},{"issue":"5","key":"key20180222110443_r15","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pntd.0001044","article-title":"Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis","volume":"5","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"key20180222110443_r16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/clinids\/3.3.397","article-title":"Syndrome of hyperinfection with Strongyloides stercoralis","volume":"3","year":"1981","journal-title":"Rev Infect Dis"},{"issue":"12","key":"key20180222110443_r17","doi-asserted-by":"crossref","first-page":"E824","DOI":"10.1503\/cmaj.090313","article-title":"Evidence-based clinical guidelines for immigrants and refugees","volume":"183","author":"coauthors of the Canadian Collaboration for Immigrant and Refugee Health","year":"2011","journal-title":"CMAJ"},{"issue":"5","key":"key20180222110443_r18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4269\/ajtmh.2001.65.610","article-title":"Influence of human T-cell lymphocytotropic virus type 1 infection on serologic and skin tests for strongyloidiasis","volume":"65","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"key20180222110443_r19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4269\/ajtmh.2001.65.346","article-title":"The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies","volume":"65","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"key20180222110443_r20","unstructured":"Public Health Agency of Canada. Canadian Malaria Network (CMN) http:\/\/www.phac-aspc.gc.ca\/tmp-pmv\/quinine\/index-eng.php"},{"issue":"6","key":"key20180222110443_r21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1017\/S0950268804003000","article-title":"The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States","volume":"132","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"2","key":"key20180222110443_r22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-3062.2009.00375.x","article-title":"Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation","volume":"11","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"key20180222110443_r23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-0711-9-27","article-title":"Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report","volume":"9","year":"2010","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"14","key":"key20180222110443_r24","first-page":"264","article-title":"Transmission of Strongyloides stercoralis through transplantation of solid organs--Pennsylvania, 2012","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9197","key":"key20180222110443_r25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)02744-0","article-title":"Parenteral ivermectin in Strongyloides hyperinfection","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"key20180222110443_r26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/630201","article-title":"Strongyloidiasis in transplant patients","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key20180222110443_r27","unstructured":"Health Canada. Guidance document for industry and practitioners: Special access programme for drugs. Ottawa ON: Health Canada; 2013. http:\/\/www.hc-sc.gc.ca\/dhp-mps\/alt_formats\/hpfb-dgpsa\/pdf\/acces\/sapg3_pasg3-eng.pdf"},{"issue":"3","key":"key20180222110443_r28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/jhin.2001.1075","article-title":"The risk of Strongyloides stercoralis transmission from patients with disseminated strongyloidiasis to the medical staff","volume":"49","year":"2001","journal-title":"J Hosp Infect"},{"issue":"5-6","key":"key20180222110443_r29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s15010-005-5060-x","article-title":"Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin","volume":"33","year":"2005","journal-title":"Infection"},{"key":"key20180222110443_r30","unstructured":"Public Health Agency of Canada. Ancylostoma duodenale. Pathogen safety data sheet \u2013 infectious substances. Ottawa ON: PHAC; 2012. http:\/\/www.phac-aspc.gc.ca\/lab-bio\/res\/psds-ftss\/ancylostoma-duodenale-eng.php"},{"issue":"5","key":"key20180222110443_r31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4269\/ajtmh.2005.73.911","article-title":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis","volume":"73","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"key20180222110443_r32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4269\/ajtmh.2008.79.853","article-title":"Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection","volume":"79","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"key20180222110443_r33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00134-005-2725-y","article-title":"Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock","volume":"31","year":"2005","journal-title":"Intensive Care Med"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/16vol42\/dr-rm42-1\/assets\/pdf\/16vol42_1_ar-03-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T11:40:45Z","timestamp":1570794045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/16vol42\/dr-rm42-1\/assets\/pdf\/16vol42_1_ar-03-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,7]]},"published-print":{"date-parts":[[2016,1,7]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v42i01a03","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}